TREAT-NMD
Global academic network
From Wikipedia, the free encyclopedia
TREAT-NMD (Translational Research in Europe, Assessment and Treatment for NeuroMuscular Disorders) is a global academic network that focuses on advancing research in neuromuscular disorders.[1] It was established in 2007 with its coordination centre at the Newcastle University.[2] As of 2018, the network comprises over a hundred research centres and patient organisations from 54 countries[3] as well as independent academics and patient representatives.[4] The network's aim is to provide infrastructure to accelerating research through supporting collaboration between its members.[5] Its main goals include improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research.[6][7]
| TREAT-NMD | |
|---|---|
| Translational Research in Europe - Assessment and Treatment of Neuromuscular diseases | |
| Keywords | Neuromuscular diseases, clinical research |
| Project type | Network of Excellence |
| Funding agency | European Commission |
| Reference | FP6-036825 |
| Objective | Improving trial-readiness worldwide, advancing patient diagnosis and care and accelerating pre-clinical research |
| Project coordinator | Institute of Genetic Medicine, Newcastle University |
| Participants | Universities, pharmaceutical companies, patient organisations |
| Website | www |
Through patient registries, TREAT-NMD provides genotype–phenotype correlation between genetic mutations and neuromuscular disease burden.[8]